| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |